https://ag555inhibitor.com/cor....rect-automatic-diagn
A pharmacodynamic style of antibody reactivity identified a decay half-life of 77-100 days and a doubling time of 46-86 times in increased proportion of survivors. The greatest antibody reactivity had been seen around 200 days after a person had recovered. The model shows that EBOV antibody reactivity diminishes over 0.5-2 years after recovery. In a high proportion of healthy survivors, antibody answers go through quick restimulation. Vigilant followup of survivors and possible optional de novo
Like
Comment
Share
